Form 4: Meta CPO Cox Receives Significant Equity Grants
Insider Transaction Disclosure
Meta Platforms' Chief Product Officer, Christopher K. Cox, was granted 79,324 Restricted Stock Units and 653,865 stock options, aligning his incentives with long-term company performance.
Summary
- Christopher K. Cox, Chief Product Officer of Meta Platforms, Inc., received new equity grants on March 20, 2026.
- The grants include 79,324 Restricted Stock Units (RSUs) of Class A Common Stock.
- The RSUs will vest quarterly as to 1/16th of the total, beginning on May 15, 2026, subject to continued service through each vesting date.
- Additionally, 653,865 stock options to acquire Class A Common Stock were granted across several tranches.
- These options have various exercise prices ranging from $1,116.08 to $3,727.12.
- All stock options have an expiration date of March 19, 2031.
- Option vesting is performance-based during a 'Price Vesting Period' from the grant date up to and including February 14, 2028; if the Class A Common Stock price meets or exceeds the exercise price for an applicable tranche, that tranche fully vests.
- Any options not vested during the Price Vesting Period will vest 6/16ths on February 15, 2028, and then 1/16th quarterly thereafter, with the final 1/16th vesting on August 15, 2030, subject to continued service.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value, though it does not directly impact immediate operational or financial performance.
Positives
- Significant equity grants align the Chief Product Officer's interests with long-term shareholder value creation.
- The grants provide a strong incentive for Christopher K. Cox to remain with Meta Platforms, Inc. and contribute to its success.
- Performance-based vesting for stock options encourages achieving specific stock price targets.
Negatives
- The issuance of new equity awards could lead to minor dilution for existing shareholders over time as RSUs vest and options are exercised.
Risks
- The value of the granted RSUs and stock options is subject to the future performance of Meta Platforms' Class A Common Stock.
- If the stock price does not reach the exercise prices of the options, or if the executive's service terminates, a portion or all of the awards may not vest or be realized.
Future Outlook
The grants outline a future vesting schedule for Christopher K. Cox's equity awards, extending through August 2030 for stock options and ongoing quarterly for RSUs starting May 2026. The performance-based vesting for options ties a significant portion of his future compensation directly to Meta's stock price appreciation.
Industry Context
StockSavvy.ai notes that granting Restricted Stock Units and stock options is a standard practice in the technology industry, particularly for senior executives at companies like Meta Platforms. This compensation structure is designed to attract, retain, and motivate key talent by aligning their financial interests with the long-term performance and growth of the company's stock.
Comparison to Industry Standards
- The structure of equity compensation, including both RSUs and performance-based stock options, is consistent with practices observed at other large technology companies such as Apple, Microsoft, and Alphabet, which frequently use similar mechanisms to incentivize executive performance and retention.
- The multi-year vesting schedules are typical for executive equity awards, aiming to foster long-term commitment rather than short-term gains.
- The inclusion of price-vesting conditions for options is a common strategy to directly link executive compensation to significant stock price appreciation, similar to performance hurdles seen in grants at companies like Tesla or Amazon for their top executives.
Stakeholder Impact
- Shareholders: Potential for minor dilution from future RSU settlement and option exercise, but also increased alignment of executive incentives with long-term stock performance.
- Employees: Standard executive compensation practices can set a precedent or benchmark for other employee equity programs.
Next Steps
- Continued service by Christopher K. Cox to meet vesting conditions for RSUs and stock options.
- Quarterly vesting of RSUs beginning May 15, 2026.
- Potential vesting of stock options if Meta's Class A Common Stock price meets or exceeds specified exercise prices during the Price Vesting Period (up to February 14, 2028).
- Scheduled vesting of unvested stock options on February 15, 2028, and quarterly thereafter until August 15, 2030.
Key Dates
| Date | Description |
|---|---|
| 03/20/2026 | Date of earliest transaction (grant date for RSUs and stock options). |
| 03/24/2026 | Signature date of the reporting person's attorney-in-fact. |
| 05/15/2026 | First vesting date for Restricted Stock Units (1/16th of total). |
| 02/14/2028 | End of the 'Price Vesting Period' for stock options. |
| 02/15/2028 | Vesting date for 6/16ths of unvested stock options after the Price Vesting Period. |
| 08/15/2030 | Final vesting date for stock options not vested during the Price Vesting Period. |
| 03/19/2031 | Expiration date for all granted stock options. |
Keywords
Meta Platforms, META, Christopher K. Cox, Chief Product Officer, SEC Form 4, Restricted Stock Units, Stock Options, Equity Compensation, Insider Transaction, Executive Compensation, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.